These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12683099)

  • 1. Yasmin advert withdrawn--why and how.
    Drug Ther Bull; 2003 Mar; 41(3):17-8. PubMed ID: 12683099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is [symbol: see text] Yasmin a "truly different" pill?
    Drug Ther Bull; 2002 Aug; 40(8):57-9. PubMed ID: 12216337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yasmin--an oral contraceptive with a new progestin.
    Med Lett Drugs Ther; 2002 Jun; 44(1133):55-7. PubMed ID: 12080274
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of Yasmin in premenstrual symptoms.
    Taneepanichskul S; Jaisamrarn U; Phupong V
    Arch Gynecol Obstet; 2007 Jun; 275(6):433-8. PubMed ID: 17111156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yasmin--a new oral contraceptive, a new progestogen: the reasons why.
    Mansour D
    Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():9-16. PubMed ID: 11246601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added benefits of drospirenone for compliance.
    Foidart JM
    Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.
    Apter D; Borsos A; Baumgärtner W; Melis GB; Vexiau-Robert D; Colligs-Hakert A; Palmer M; Kelly S
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):37-51. PubMed ID: 12725674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yasmin and venous thromboembolism: new case reports.
    López M; Vayá A; Martínez Triguero ML; Contreras MT; Todolí J; Ricart A; Laiz B
    Clin Hemorheol Microcirc; 2009; 42(1):65-9. PubMed ID: 19363241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAZ and the novel progestin drospirenone.
    Mishell DR
    J Reprod Med; 2008 Sep; 53(9 Suppl):721-8. PubMed ID: 18980044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Venous thromboembolism and combined oral contraceptives. Reported adverse reactions indicate at least similar risk with the most recent contraceptive pills].
    Kieler H; Persson I; Odlind V
    Lakartidningen; 2003 Sep; 100(39):3050-2. PubMed ID: 14560670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
    Somma MA
    Am Fam Physician; 2004 May; 69(10):2425-6. PubMed ID: 15168965
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of an oral contraceptive containing drospirenone in an extended regimen.
    Sillem M; Schneidereit R; Heithecker R; Mueck AO
    Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):162-9. PubMed ID: 14667328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayer to spend $20m to correct misleading advertising for oral contraceptive Yaz.
    Tanne JH
    BMJ; 2009 Feb; 338():b674. PubMed ID: 19223342
    [No Abstract]   [Full Text] [Related]  

  • 16. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
    Oranratanaphan S; Taneepanichskul S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S17-22. PubMed ID: 17726807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient ischaemic attack associated with the new contraceptive Yasmin.
    Vayá A; Mira Y; Ferrando F; Aznar J; García-Fuster MJ
    Thromb Res; 2003; 112(1-2):121. PubMed ID: 15013284
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of a third generation combined oral contraceptive pill on the classical singing voice.
    Lã FM; Ledger WL; Davidson JW; Howard DM; Jones GL
    J Voice; 2007 Nov; 21(6):754-61. PubMed ID: 16887327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of yasmin in the treatment of women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Ivancheva Kh; Amaliev I
    Akush Ginekol (Sofiia); 2006; 45(3):25-9. PubMed ID: 16889184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials.
    Roumen FJ
    Contraception; 2007 Jun; 75(6):420-9. PubMed ID: 17519147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.